What is the average price target for NUTRIEN LTD (NTR) stock?
27 analysts have analysed NTR and the average price target is 54.16 USD. This implies a price decrease of -28.41% is expected in the next year compared to the current price of 75.65.
NYSE:NTR • CA67077M1086
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NUTRIEN LTD (NTR).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-26 | UBS | Downgrade | Neutral -> Sell |
| 2026-03-18 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-03-18 | B of A Securities | Maintains | Neutral -> Neutral |
| 2026-03-17 | CIBC | Maintains | Outperformer -> Outperformer |
| 2026-03-13 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2026-03-12 | Jefferies | Upgrade | Hold -> Buy |
| 2026-03-03 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-26 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-02-23 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-23 | Jefferies | Maintains | Hold -> Hold |
| 2026-02-20 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-20 | B of A Securities | Maintains | Neutral -> Neutral |
| 2026-02-18 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-02 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2026-01-20 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-16 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-01-14 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2026-01-12 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-18 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-11-11 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-10 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-11-06 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-16 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 29.056B -23.30% | 25.972B -10.61% | 26.885B 3.52% | 26.401B -1.80% | 26.496B 0.36% | 26.635B 0.52% | 28.149B 5.68% | 28.634B 1.72% | 29.715B 3.78% | 30.356B 2.16% | 31.01B 2.15% | |
| EBITDA YoY % growth | 5.971B -49.65% | 5.288B -11.44% | 5.954B 12.59% | 6.136B 3.06% | 6.065B -1.16% | 6.121B 0.92% | 6.061B -0.98% | 6.254B 3.18% | 6.448B 3.10% | 6.55B 1.58% | 6.652B 1.56% | |
| EBIT YoY % growth | 3.802B -61.39% | 2.949B -22.44% | 3.585B 21.57% | 4.355B 21.48% | 3.922B -9.94% | 3.713B -5.33% | 3.51B -5.47% | 3.978B 13.33% | 3.866B -2.82% | 3.93B 1.66% | 3.995B 1.65% | |
| Operating Margin | 13.09% | 11.35% | 13.33% | 16.50% | 14.80% | 13.94% | 12.47% | 13.89% | 13.01% | 12.95% | 12.88% | |
| EPS YoY % growth | 4.36 -66.67% | 3.50 -19.72% | 4.56 30.29% | 4.81 5.57% | 4.76 -1.13% | 4.89 2.73% | 5.07 3.62% | 4.95 -2.23% | 4.96 0.10% | 5.05 1.83% | 5.15 2.00% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.52 370.24% | 2.76 4.27% | 0.93 -3.97% | 0.86 3.25% | 0.56 7.78% | 2.81 1.55% | 0.87 -6.11% | 0.87 1.36% |
| Revenue Q2Q % growth | 5.263B 7.98% | 10.249B 0.50% | 5.539B -3.42% | 5.162B 0.39% | 5.372B 2.07% | 10.628B 3.70% | 5.784B 4.42% | 5.309B 2.85% |
| EBITDA Q2Q % growth | 1.082B 31.95% | 2.511B -16.99% | 1.351B -47.92% | 1.248B -59.39% | 1.079B -0.28% | 2.454B -2.27% | 1.346B -0.37% | 1.254B 0.48% |
| EBIT Q2Q % growth | 481.77M 93.48% | 1.885B 2.45% | 655.89M -17.19% | 674.94M -4.13% | N/A | N/A | N/A | N/A |
All data in USD
27 analysts have analysed NTR and the average price target is 54.16 USD. This implies a price decrease of -28.41% is expected in the next year compared to the current price of 75.65.
NUTRIEN LTD (NTR) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of NUTRIEN LTD (NTR) is 0.52 USD and the consensus revenue estimate is 5.26B USD.
The number of analysts covering NUTRIEN LTD (NTR) is 27.